Stirling Products Limited (ASX:STI) Gets Approval For TB and HIV Treatment "Immunoxel" In South Africa

  Sydney, Australia, May 26, 2009 - (ABN Newswire) - Australian healthcare company Stirling Products Limited (ASX:STI) is pleased to announce another milestone in the expansion of the licensed (pending joint venture approval) botanical products to markets outside of Ukraine. Immunoxel (Dzherelo) has been granted approval in South Africa. This approval will allow immediate sales of the phytoconcentrate as an immune adjuvant for TB and HIV treatment.  

Sydney

  [ Change ]
 
Today

Min: 12°
Max: 19°
A few showers.
Tomorrow

Min: 13°
Max: 18°
Rain.
 

Account

Login

To access your account and listings



Remember me
   
   
   
 
 
Find Hunter Valley accommodation online